Cardiac inflammation contributes to changes in the extracellular matrix in patients with heart failure and normal ejection fraction

D Westermann, D Lindner, M Kasner… - Circulation: Heart …, 2011 - Am Heart Assoc
D Westermann, D Lindner, M Kasner, C Zietsch, K Savvatis, F Escher, J Von Schlippenbach…
Circulation: Heart Failure, 2011Am Heart Assoc
Background—The pathophysiology of heart failure with normal ejection fraction (HFNEF) is
still under discussion. Here we report the influence of cardiac inflammation on extracellular
matrix (ECM) remodeling in patients with HFNEF. Methods and Results—We investigated
left ventricular systolic and diastolic function in 20 patients with HFNEF and 8 control
patients by conductance catheter methods and echocardiography. Endomyocardial biopsy
samples were also obtained, and ECM proteins as well as cardiac inflammatory cells were …
Background
The pathophysiology of heart failure with normal ejection fraction (HFNEF) is still under discussion. Here we report the influence of cardiac inflammation on extracellular matrix (ECM) remodeling in patients with HFNEF.
Methods and Results
We investigated left ventricular systolic and diastolic function in 20 patients with HFNEF and 8 control patients by conductance catheter methods and echocardiography. Endomyocardial biopsy samples were also obtained, and ECM proteins as well as cardiac inflammatory cells were investigated. Primary human cardiac fibroblasts were outgrown from the endomyocardial biopsy samples to investigate the gene expression of ECM proteins after stimulation with transforming growth factor-β. Diastolic dysfunction was present in the HFNEF patients compared with the control patients. In endomyocardial biopsy samples from HFNEF patients, we found an accumulation of cardiac collagen, which was accompanied by a decrease in the major collagenase system (matrix metalloproteinase-1) in the heart. Moreover, a subset of inflammatory cells, which expressed the profibrotic growth factor transforming growth factor-β, could be documented in the HFNEF patients. Stimulation of primary human cardiac fibroblasts from HFNEF patients with transforming growth factor-β resulted in transdifferentiation of fibroblasts to myofibroblasts, which produced more collagen and decreased the amount of matrix metalloproteinase-1, the major collagenase in the human heart. A positive correlation between cardiac collagen, as well as the amount of inflammatory cells, and diastolic dysfunction was evident and suggests a direct influence of inflammation on fibrosis triggering diastolic dysfunction.
Conclusions
Cardiac inflammation contributes to diastolic dysfunction in HFNEF by triggering the accumulation of ECM.
Am Heart Assoc